SHARPIN regulates uropod detachment in migrating lymphocytes

Cell Reports

Volumn 5, Issue 3, 2013, Pages 619-628

  Pouwels, Jeroen ^a,b   DeFranceschi, Nicola ^a,b   Rantakari, Pia ^c   Auvinen, Kaisa ^c,g   Karikoski, Marika ^c   Mattila, Elina ^a   Potter, Christopher ^d   Sundberg, John P ^d   Hogg, Nancy ^e   Gahmberg, Carl G ^f   Salmi, Marko ^b,c,g   Ivaska, Johanna ^a,b  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d JACKSON LABORATORY   (United States)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f UNIVERSITY OF HELSINKI   (Finland)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE RECEPTOR; PROTEIN SHARPIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; SHARPIN PROTEIN, HUMAN; SIPL1 PROTEIN, MOUSE; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CELL ADHESION; CELL DAMAGE; CELL POLARITY; CONTROLLED STUDY; ENDOTHELIUM CELL; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL MOTION; CELL SURFACE; CYTOLOGY; HEK293 CELL LINE; HUMAN; LYMPHOCYTE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

MUS; UROPODA;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL ADHESION; CELL MOVEMENT; CELL POLARITY; CELL SURFACE EXTENSIONS; HEK293 CELLS; HUMANS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; UBIQUITINS;

EID: 84887614255     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.10.011     Document Type: Article

References (40)

1. Abram C.L., Lowell C.A. The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 2009, 27:339-362.
2. Bolomini-Vittori M., Montresor A., Giagulli C., Staunton D., Rossi B., Martinello M., Constantin G., Laudanna C. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat. Immunol. 2009, 10:185-194.
3. Constantin G., Majeed M., Giagulli C., Piccio L., Kim J.Y., Butcher E.C., Laudanna C. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 2000, 13:759-769.
4. Dransfield I., Hogg N. Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO J. 1989, 8:3759-3765.
5. Franco S.J., Rodgers M.A., Perrin B.J., Han J., Bennin D.A., Critchley D.R., Huttenlocher A. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat. Cell Biol. 2004, 6:977-983.
6. Gahmberg C.G., Fagerholm S.C., Nurmi S.M., Chavakis T., Marchesan S., Grönholm M. Regulation of integrin activity and signalling. Biochim. Biophys. Acta 2009, 1790:431-444.
7. Gerlach B., Cordier S.M., Schmukle A.C., Emmerich C.H., Rieser E., Haas T.L., Webb A.I., Rickard J.A., Anderton H., Wong W.W., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011, 471:591-596.
8. Gómez-Móuton C., Abad J.L., Mira E., Lacalle R.A., Gallardo E., Jiménez-Baranda S., Illa I., Bernad A., Mañes S., Martínez-A C. Segregation of leading-edge and uropod components into specific lipid rafts during Tcell polarization. Proc. Natl. Acad. Sci. USA 2001, 98:9642-9647.
9. HogenEsch H., Gijbels M.J., Offerman E., van Hooft J., van Bekkum D.W., Zurcher C. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 1993, 143:972-982.
10. Hogg N., Patzak I., Willenbrock F. The insider's guide to leukocyte integrin signalling and function. Nat. Rev. Immunol. 2011, 11:416-426.
11. Hyun Y.M., Sumagin R., Sarangi P.P., Lomakina E., Overstreet M.G., Baker C.M., Fowell D.J., Waugh R.E., Sarelius I.H., Kim M. Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels. J.Exp. Med. 2012, 209:1349-1362.
12. Ikeda F., Deribe Y.L., Skånland S.S., Stieglitz B., Grabbe C., Franz-Wachtel M., van Wijk S.J., Goswami P., Nagy V., Terzic J., et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 2011, 471:637-641.
13. Katagiri K., Maeda A., Shimonaka M., Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat. Immunol. 2003, 4:741-748.
14. Kinashi T. Integrin regulation of lymphocyte trafficking: lessons from structural and signaling studies. Adv. Immunol. 2007, 93:185-227.
15. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
16. Liang Y., Seymour R.E., Sundberg J.P. Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. J.Invest. Dermatol. 2011, 131:141-149.
17. Lu C.F., Springer T.A. The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte function-associated antigen-1. J.Immunol. 1997, 159:268-278.
18. Mattila E., Pellinen T., Nevo J., Vuoriluoto K., Arjonen A., Ivaska J. Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat. Cell Biol. 2005, 7:78-85.
19. Morin N.A., Oakes P.W., Hyun Y.M., Lee D., Chin Y.E., King M.R., Springer T.A., Shimaoka M., Tang J.X., Reichner J.S., Kim M. Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J.Exp. Med. 2008, 205:195-205.
20. Moser M., Legate K.R., Zent R., Fässler R. The tail of integrins, talin, and kindlins. Science 2009, 324:895-899.
21. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997, 385:537-540.
22. Park E.J., Peixoto A., Imai Y., Goodarzi A., Cheng G., Carman C.V., von Andrian U.H., Shimaoka M. Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes. Blood 2010, 115:1572-1581.
23. Rantala J.K., Pouwels J., Pellinen T., Veltel S., Laasola P., Mattila E., Potter C.S., Duffy T., Sundberg J.P., Kallioniemi O., et al. SHARPIN is an endogenous inhibitor of β1-integrin activation. Nat. Cell Biol. 2011, 13:1315-1324.
24. Reichardt P., Patzak I., Jones K., Etemire E., Gunzer M., Hogg N. A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes. EMBO J. 2013, 32:829-843.
25. Renninger M.L., Seymour R.E., Whiteley L.O., Sundberg J.P., Hogenesch H. Anti-iL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice. Exp. Dermatol. 2010, 19:252-258.
26. Robinson M.K., Andrew D., Rosen H., Brown D., Ortlepp S., Stephens P., Butcher E.C. Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J.Immunol. 1992, 148:1080-1085.
27. Semmrich M., Smith A., Feterowski C., Beer S., Engelhardt B., Busch D.H., Bartsch B., Laschinger M., Hogg N., Pfeffer K., Holzmann B. Importance of integrin LFA-1 deactivation for the generation of immune responses. J.Exp. Med. 2005, 201:1987-1998.
28. Seymour R.E., Hasham M.G., Cox G.A., Shultz L.D., Hogenesch H., Roopenian D.C., Sundberg J.P. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 2007, 8:416-421.
29. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 2010, 11:288-300.
30. Smith A., Carrasco Y.R., Stanley P., Kieffer N., Batista F.D., Hogg N. A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. J.Cell Biol. 2005, 170:141-151.
31. Stanley P., Smith A., McDowall A., Nicol A., Zicha D., Hogg N. Intermediate-affinity LFA-1 binds alpha-actinin-1 to control migration at the leading edge of the Tcell. EMBO J. 2008, 27:62-75.
32. Tokunaga F., Sakata S., Saeki Y., Satomi Y., Kirisako T., Kamei K., Nakagawa T., Kato M., Murata S., Yamaoka S., et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol. 2009, 11:123-132.
33. Tokunaga F., Nakagawa T., Nakahara M., Saeki Y., Taniguchi M., Sakata S., Tanaka K., Nakano H., Iwai K. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 2011, 471:633-636.
34. Vestweber D. Novel insights into leukocyte extravasation. Curr. Opin. Hematol. 2012, 19:212-217.
35. Wang Z., Sokolovska A., Seymour R., Sundberg J.P., Hogenesch H. SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells. PLoS ONE 2012, 7:e31809.
36. Wernimont S.A., Legate K.R., Simonson W.T., Fassler R., Huttenlocher A. PIPKI gamma 90 negatively regulates LFA-1-mediated adhesion and activation in antigen-induced CD4+ Tcells. J.Immunol. 2010, 185:4714-4723.
37. Wülfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during Tcell activation. Science 1998, 282:2266-2269.
38. Yang W., Carman C.V., Kim M., Salas A., Shimaoka M., Springer T.A. A small molecule agonist of an integrin, alphaLbeta2. J.Biol. Chem. 2006, 281:37904-37912.
39. Zak D.E., Schmitz F., Gold E.S., Diercks A.H., Peschon J.J., Valvo J.S., Niemistö A., Podolsky I., Fallen S.G., Suen R., et al. Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc. Natl. Acad. Sci. USA 2011, 108:11536-11541.
40. Zhang W., Shao Y., Fang D., Huang J., Jeon M.S., Liu Y.C. Negative regulation of Tcell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J.Biol. Chem. 2003, 278:23978-23983.